SOLV Solventum (SOLV) Q4 FY25 earnings call
Solventum closed its first full year as an independent company with strong Q4 FY25 organic sales growth, driven by MedSurg and Dental, and accelerated progress on portfolio optimization through the Acera acquisition and P&F divestiture. Despite gross margin and free cash flow headwinds in the quarter, the company exceeded full-year sales and restructuring savings targets, positioning it for continued momentum and margin expansion in FY26, supported by new product launches and the Transform for the Future program.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
SOLV operating KPIs by quarter
| KPI | This call Dec 2025 Q4 FY25 | Mar 2026 Q1 FY26 | Change vs prior quarter |
|---|---|---|---|
| Distribution centers | 55Regarding supply chain, we've taken further steps to separate from 3M and have now reduced our distribution center network to 55 locations, progressing towards our goal of 45.Source: earnings call transcript | 54With further work to streamline our distribution centers, we are now down to 54 worldwide.Source: earnings call transcript | -1.8% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.